X0306 4 2016-03-29 0001456189 Leatt Corp LEAT 0001553632 Leatt Christopher James 12 KIEPERSOL DRIVE, ATLAS GARDENS CONTERMANSKLOOF ROAD DURBANVILLE, WESTERN CAPE T3 7441 SOUTH AFRICA 1 0 1 0 Common Stock, par value $0.001 per share 2016-09-01 4 F 0 31200 1.00 A 2030114 I See footnote 2 Options to purchase Common Stock, par value $0.001 per share 2.60 2016-03-29 2016-03-29 4 A 0 52000 0.00 A 2016-03-29 2026-03-28 Common Stock, par value $0.001 per share 52000 200000 D Options to purchase Common Stock, par value $0.001 per share 1.00 2016-09-01 2016-09-01 4 M 0 31200 0.00 D 2012-02-01 2017-02-01 Common Stock, par value $0.001 per share 31200 148000 D Options to purchase Common Stock, par value $0.001 per share 1.60 2017-08-24 2017-08-24 4 A 0 52000 0.00 A 2017-12-31 2027-08-23 Common Stock, par value $0.001 per share 52000 200000 D On February 1, 2012, the Issuer's Board of Directors approved a grant to the Reporting Person, of a 5-year option to purchase 1,300,000 shares of the Issuer's common stock at $0.04 per share under the Issuer's 2011 Plan. After giving effect to the Reverse Split, the Reporting Person had vested options to purchase 52,000 shares of the Company's common stock at $1.00 per share. On September 1, 2016, the Reporting Person exercised his option to purchase all 52,000 shares at an aggregate exercise price of $52,000. The purchase price was paid through a cashless transaction whereby the Issuer withheld 20,800 of the shares and the Reporting person received the remaining 31,200 shares. Total common stock represents 2,025,107 shares of the Issuer's common stock directly held by the Reporting Person and 5,007 shares of the Issuer's common stock held by members of the Reporting Person's immediate family. On March 29, 2016, the Issuer's Board of Directors approved a grant to the Reporting Person of a 10-year option to purchase another 52,000 shares of the Issuer's common stock at an exercise price of $2.60 a share under the Issuer's 2011 Plan, 15,600 of which immediately vested and an additional 15,600 of which vested on March 29, 2017. The remaining options to purchase 20,800 shares are scheduled to vest in equal parts on March 29, 2018 and 2019, respectively. Total derivative securities include options to purchase shares of the Issuer's common stock, held as at the transaction date, and 96,000 shares of the Issuer's preferred stock held by the Reporting Person, convertible to common stock at a rate of 1 share of common stock for each share of preferred stock. On August 24, 2017, the Issuer's Board of Directors approved a grant to the Reporting Person of another 10-year option to purchase 52,000 shares of the Issuer's common stock at an exercise price of $1.60 a share under the Issuer's 2011 Plan, 20,800 of the options will vest on December 31, 2017 and the remaining options to purchase 15,600 shares and 15,600 shares will vest on December 31, 2018 and 2019, respectively. /s/ Christopher J. Leatt 2017-10-16